Research Interests
cancer/oncogenesis
,
epidemiology
,
genetics/genome
,
health services, research/outc
,
men?s health issues
Recent Publications
Lu Y, Sun J, Kader AK, Kim S-T, Kim J-W, Liu W, Sun J, Lu D, Feng J, Zhu Y, Jin T, Zhang Z, Dimitrov L, Lowey J, Campbell K, Suh E, Duggan D, Carpten J, Trent JM, Gronberg H, Zheng SL, Isaacs WB, Xu J.
Association of prostate cancer risk with SNPs in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses. Prostate.
2012;
72(4):376-385.
Lu L, Cancel-Tassin G, Valeri A, Cussenot O, Lange EM, Cooney KA, Farnham JM, Camp NJ, Zheng SL, Xu J, et al.
Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG. Prostate.
2012;
72(4):410-426.
Shao Q, Ouyang J, Fan Y, Xie J, Zhou J, Wu J, Kader AK, Xu J, Liu G, Shan Y, Wen D, Zhang Y.
Prostate cancer in the senior men from rural areas in east district of China: contemporary management and 5-year outcomes at multi-institutional collaboration. Cancer Lett.
2012;
315(2):170-177.
Wang M, Liu F, Hsing AW, Wang X, Shao Q, Zhang Y, Jin G, Sun J, Zheng SL, Xu J, et al.
Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: a case-control study in the ChinaPCa consortium. Carcinogenesis.
2012;
33(2):356-360.
Hester JM, Wing MR, Li J, Palmer ND, Xu J, Hicks PJ, Roh BH, Norris JM, Wagenknecht LE, Langefeld CD, Freedman BI, Bowden DW, Ng MCY.
Implication of European-derived adiposity loci in African Americans. Int J Obes (Lond).
2012;
36(3):465-473.
Palmer N, Turner A, Xu J, Avis N.
African-American prostate cancer survivors' treatment decision-making and quality of life [abstract]. Psychooncology.
2012;
21(Suppl 1):18-19.
Tao S, Wang Z, Feng J, Hsu F-C, Jin G, Kim S-T, Zhang Z, Gronberg H, Zheng LS [sic] [Zheng SL], Isaacs WB, Xu J, Sun J.
A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants. Carcinogenesis.
2012;
33(3):598-603.
Wen W, Cho Y-S, Zheng W, Dorajoo R, Kato N, Qi L, Chen C-H, Delahanty RJ, Okada Y, Xu J, et al.
Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet.
2012;
44(3):307-311.
Zheng J, Liu F, Lin X, Wang X, Ding Q, Jiang H, Chen H, Lu D, Jin G, Hsing AW, Shao Q, Qi J, Ye Y, Wang Z, Gao X, Wang G, Chu LW, OuYang J, Huang Y, Chen Y, Gao Y, Shi R, Wu Q, Wang M, Zhang Z, Hu Y, Sun J, Zheng SL, Gao X, Xu C.
Predictive performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk-associated SNPs. Prostate.
2012;
72(5):577-583.
Sun J, Kader AK, Hsu F-C, Kim S-T, Zhu Y, Turner AR, Jin T, Zhang Z, Zheng SL, Xu J, et al.
Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer. Prostate.
2011;
71(4):421-430.
Chang B-L, Spangler E, Gallagher S, Haiman CA, Henderson B, Isaacs W, Benford ML, Kidd LR, Cooney K, Xu J, et al.
Validation of genome-wide prostate cancer associations in men of African descent. Cancer Epidemiol Biomarkers Prev.
2011;
20(1):23-32.
Chen H, Chen Y, Zhao Y, Fan W, Zhou K, Liu Y, Zhou L, Mao Y, Wei Q, Xu J, Lu D.
Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population. Am J Epidemiol.
2011;
173(8):915-922.
Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Xu J, Zheng SL, et al.
Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet.
2011;
43(6):570-573.
Chung CC, Ciampa J, Yeager M, Jacobs KB, Berndt SI, Hayes RB, Gonzalez-Bosquet J, Kraft P, Wacholder S, Xu J, et al.
Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. Hum Mol Genet.
2011;
20(14):2869-2878.
Jin G, Sun J, Liu W, Zhang Z, Chu LW, Kim S-T, Sun J, Feng J, Zheng SL, Xu J, et al.
Genome-wide copy-number variation analysis identifies common genetic variants at 20p13 associated with aggressiveness of prostate cancer. Carcinogenesis.
2011;
32(7):1057-1062.
Berndt SI, Sampson J, Yeager M, Jacobs KB, Wang Z, Hutchinson A, Chung C, Xu J, Zheng SL, Sun J, et al.
Large-scale fine mapping of the HNF1B locus and prostate cancer risk. Hum Mol Genet.
2011;
20(16):3322-3329.
Humphreys K, Grankvist A, Leu M, Hall P, Liu J, Ripatti S, Rehnstrom K, Groop L, Klareskog L, Xu J, et al.
The genetic structure of the Swedish population. PLoS ONE.
2011;
6(8):e22547.
Lin DW, FitzGerald LM, Fu R, Kwon EM, Zheng SL, Kolb S, Wiklund F, Stattin P, Isaacs WB, Xu J, et al.
Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality. Cancer Epidemiol Biomarkers Prev.
2011;
20(9):1928-1936.
Schumacher FR, Berndt SI, Siddiq A, Jacobs KB, Wang Z, Lindstrom S, Stevens VL, Chen C, Mondul AM, Xu J, et al.
Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet.
2011;
20(19):3867-3875.
Cooke J, Ng M, Lu L, Li J, An S, Hester J, Xu J, Freedman B, Langefeld C, Bowden D, Palmer N.
Genetic risk assessment of type 2 diabetes associated polymorphisms in African-Americans [abstract]. In: Abstracts of the 61st Annual Meeting of the American Society of Human Genetics; 2011 Oct 11-15; Montreal (Canada).
2011;
():.
Liu F, Hsing AW, Wang X, Shao Q, Qi J, Ye Y, Jin G, Sun J, Zheng SL, Xu J, et al.
Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men. Cancer Sci.
2011;
102(10):1916-1920.
Jin G, Sun J, Isaacs SD, Wiley KE, Kim S-T, Chu LW, Zhang Z, Zhao H, Zheng SL, Isaacs WB, Xu J.
Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk. Carcinogenesis.
2011;
32(11):1655-1659.
Lotan TL, Gurel B, Sutcliffe S, Esopi D, Liu W, Xu J, Hicks JL, Park BH, Humphreys E, Partin AW, et al.
PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients. Clin Cancer Res.
2011;
17(20):6563-6573.
Tong N, Fang Y, Li J, Wang M, Lu Q, Wang S, Tian Y, Rong L, Sun J, Xu J, et al.
Methylenetetrahydrofolate reductase polymorphisms, serum methylenetetrahydrofolate reductase levels, and risk of childhood acute lymphoblastic leukemia in a Chinese population. Cancer Sci.
2010;
101(3):782-786.
Xu J, Zheng SL, Isaacs SD, Wiley KE, Sun J, Kader AK, Li G, Purcell LD, Kim S-T, Hsu F-C, et al.
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. Proc Natl Acad Sci U S A.
2010;
107(5):2136-2140.
Zheng SL, Hsing AW, Sun J, Chu LW, Yu K, Li G, Gao Z, Kim S-T, Isaacs WB, Xu J, et al.
Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men. Prostate.
2010;
70(4):425-432.
Hsu F-C, Sun J, Zhu Y, Kim S-T, Jin T, Zhang Z, Wiklund F, Kader AK, Zheng SL, Xu J, et al.
Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history. Cancer Epidemiol Biomarkers Prev.
2010;
19(4):1083-1088.
Klein RJ, Hallden C, Cronin AM, Ploner A, Wiklund F, Bjartell AS, Stattin P, Xu J, Scardino PT, Offit K, et al.
Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer. Cancer Prev Res (Phila Pa).
2010;
3(5):611-619.
Prokunina-Olsson L, Fu Y-P, Tang W, Jacobs KB, Hayes RB, Kraft P, Berndt SI, Wacholder S, Yu K, Xu J, et al.
Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2. Cancer Epidemiol Biomarkers Prev.
2010;
19(5):1349-1355.
Christensen GB, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Dimitrov L, Xu J, et al.
Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. Prostate.
2010;
70(7):735-744.
Elliott KS, Zeggini E, McCarthy MI, Gudmundsson J, Sulem P, Stacey SN, Thorlacius S, Amundadottir L, Gronberg H, Xu J, et al.
Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies. PLoS ONE.
2010;
5(5):e10858.
Haffner MC, Aryee MJ, Toubaji A, Esopi DM, Albadine R, Gurel B, Isaacs WB, Bova GS, Liu W, Xu J, et al.
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nat Genet.
2010;
42(8):668-675.
Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, Willer CJ, Jackson AU, Vedantam S, Xu J, et al.
Hundreds of variants clustered in genomic loci and biological pathways affect human height [research letter]. Nature.
2010;
467(7317):832-838.
Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, Allen HL, Lindgren CM, Luan J, Xu J, et al.
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet.
2010;
42(11):937-948.
Gronberg H, Xu J, Isaacs WB.
Individualized prediction of prostate cancer using genetic markers [abstract]. EJC Suppl.
2010;
8(5):158.
Cheng Y, Kim JW, Liu W, Dunn TA, Luo J, Loza MJ, Kim S-T, Zheng SL, Xu J, Chang B-L, et al.
Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer. Prostate.
2009;
69(3):327-335.
Sun J, Zheng SL, Li G, Kim S-T, Zhu Y, Zhang Z, Hsu F-C, Turner AR, Liu W, Kim JW, Xu J, Chang B-L, et al.
Sequence variants at 22q13 are associated with prostate cancer risk. Cancer Res.
2009;
69(1):10-15.
Zheng SL, Sun J, Gao Z, Purcell LD, Hsu F-C, Zhu Y, Turner AR, Adams TS, Liu W, Chang B-L, Xu J, et al.
Genetic variants and family history predict prostate cancer similar to prostate-specific antigen. Clin Cancer Res.
2009;
15(3):1105-1111.
Liu W, Sun J, Li G, Zhu Y, Zhang S, Kim S-T, Sun J, Xu J, Zheng SL, Chang B-L, et al.
Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer. Cancer Res.
2009;
69(6):2176-2179.
Wiklund F, Zheng SL, Sun J, Adami H-O, Lilja H, Hsu F-C, Stattin P, Cramer SD, Chang B-L, Xu J, et al.
Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer. Prostate.
2009;
69(4):419-427.
Chang B-L, Cramer SD, Sun J, Smith S, Pruett K, Romero LM, Zhu Y, Zhang Z, Hsu F-C, Turner AR, Liu W, Kim JW, Zheng SL, Xu J, et al.
Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. Hum Mol Genet.
2009;
18(7):1368-1375.
Hsu F-C, Sun J, Purcell LD, Gao Z, Zhu Y, Kim S-T, Zhang Z, Liu W, Chang B-L, Xu J, Zheng SL, et al.
A novel prostate cancer susceptibility locus at 19q13. Cancer Res.
2009;
69(7):2720-2723.
Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J, Yu G, Chen L, Ewing CM, Eisenberger MA, Xu J, et al.
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer [letter]. Nat Med.
2009;
15(5):559-565.
Zheng SL, Sun J, Smith S, Pruett K, Kim S-T, Zhu Y, Zhang Z, Hsu F-C, Turner AR, Liu W, Kim JW, Chang B-L, Xu J, et al.
Two independent prostate cancer risk-associated Loci at 11q13. Cancer Epidemiol Biomarkers Prev.
2009;
18(6):1815-1820.
Xu J, Sun J, Kader AK, Lindstrom S, Wiklund F, Hsu F-C, Kim S-T, Johansson J-E, Zheng SL, Platz EA, et al.
Estimation of absolute risk for prostate cancer from blood DNA [abstract]. J Urol.
2009;
181(4 Suppl):643.
Kader AK, Sun J, Isaacs SD, Wiley KE, Yan G, Kim S-T, Fedor H, DeMarzo AM, Zheng SL, Xu J, et al.
Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients. Prostate.
2009;
69(11):1195-1205.
Lu L, Sun J, Isaacs SD, Smith S, Pruett K, Zhu Y, Zhang Z, Chang B-L, Zheng SL, Xu J, et al.
Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11. Cancer Epidemiol Biomarkers Prev.
2009;
18(7):2132-2136.
Xu J, Kibel AS, Turner AR, Pruett K, Zheng SL, Sun J, Kim S-T, Hsu F-C, Torti FM, Chang B-L, et al.
Prostate cancer risk associated loci in African Americans. Cancer Epidemiol Biomarkers Prev.
2009;
18(7):2145-2149.
Khoury MJ, McBride CM, Schully SD, Ioannidis JPA, Feero WG, Janssens ACJW, Gwinn M, Simons-Morton DG, Bernhardt JM, Xu J, et al.
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med.
2009;
11(8):559-567.
Xu J, Sun J, Kader AK, Lindstrom S, Wiklund F, Hsu F-C, Johansson J-E, Zheng SL, Thomas G, Hayes RB, et al.
Estimation of absolute risk for prostate cancer using genetic markers and family history. Prostate.
2009;
69(14):1565-1572.
Yeager M, Chatterjee N, Ciampa J, Jacobs KB, Gonzalez-Bosquet J, Hayes RB, Kraft P, Xu J, Zheng SL, Sun J, et al.
Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet.
2009;
41(10):1055-1057.
Brown DA, Lindmark F, Stattin P, Balter K, Adami H-O, Zheng SL, Xu J, Isaacs WB, Gronberg H, Breit SN, et al.
Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer. Clin Cancer Res.
2009;
15(21):6658-6664.
Koppelman GH, Meyers DA, Howard TD, Zheng SL, Hawkins GA, Ampleford EJ, Xu J, Koning H, Bruinenberg M, Bleecker ER, et al.
Identification of PCDH1 as a novel susceptibility gene for bronchial hyperresponsiveness. Am J Respir Crit Care Med.
2009;
180(10):929-935.
Bostrom MA, Lu L, Chou J, Hicks PJ, Xu J, Langefeld CD, Freedman BI, Bowden DW.
Genome wide association study of non-diabetic end stage renal disease in African Americans using pooled DNA [abstract]. Presented at the 59th Annual Meeting of The American Society of Human Genetics, October 21, 2009, Honolulu, Hawaii.
2009;
():A676.
Koppelman GH, Meyers DA, Howard TD, Zheng SL, Hawkins GA, Ampleford EA, Xu J, Koning H, Bruinenberg M, Bleecker ER, et al.
Identification of protocadherin-1 as a novel susceptibility gene for bronchial hyperresponsiveness and asthma [abstract]. Am J Respir Crit Care Med.
2009;
179(1 Meeting Abstracts):A2447.
Xu J, Zheng SL, Herrington DM, Bleecker E, Meyers D, Isaacs W, Walsh P, inventors; Wake Forest University Health Sciences, assignee.
Mutations in the macrophage scavenger receptor 1 gene alter risk of prostate cancer, asthma, and cardiovascular disease. United States patent US 7,579,147. 2009 Aug 25.
2009;
():.
Sun J, Lange EM, Isaacs SD, Liu W, Wiley KE, Lange L, Gronberg H, Xu J, Chang B-L, Zheng SL, et al.
Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients. Prostate.
2008;
68(5):489-497.
Zheng SL, Sun J, Smith S, Li G, Hsu F-C, Zhu Y, Kader AK, Turner AR, Liu W, Bleecker ER, Meyers DA, Chang B-L, Xu J, et al.
Cumulative association of five genetic variants with prostate cancer. N Engl J Med.
2008;
358(9):910-919.
Chen S-H, Sun J, Dimitrov L, Turner AR, Adams TS, Meyers DA, Chang B-L, Zheng SL, Xu J, Hsu F-C, et al.
A support vector machine approach for detecting gene-gene interaction. Genet Epidemiol.
2008;
32(2):152-167.
Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D, Zheng SL, Sun J, Chang B-L, Xu J, et al.
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet.
2008;
40(3):281-283.
Sun J, Purcell L, Gao Z, Isaacs SD, Wiley KE, Hsu F-C, Liu W, Xu J, Chang B-L, Zheng SL, et al.
Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans. Prostate.
2008;
68(7):691-697.
Jacobs EJ, Hsing AW, Bain EB, Stevens VL, Wang Y, Chen J, Chanock SJ, Zheng SL, Xu J, Thun MJ, et al.
Polymorphisms in angiogenesis-related genes and prostate cancer. Cancer Epidemiol Biomarkers Prev.
2008;
17(4):972-977.
Hsu F-C, Lindstrom S, Sun J, Wiklund F, Turner AR, Liu W, Kim JW, Chang B-l, Xu J, Zheng SL, et al.
A multigenic approach to evaluating prostate cancer risk in a systematic replication study. Cancer Genet Cytogenet.
2008;
183(2):94-98.
Kader AK, Sun J, Yang G, Zheng L, Xu J, Liu W, Issacs WB.
Loss of chromosome 17p13.1 significantly correlates with Gleason score at the time of radical prostatectomy [abstract]. J Urol.
2008;
179(4 Suppl):227-228.
Sun J, Chang B-L, Isaacs SD, Wiley KE, Wiklund F, Stattin P, Duggan D, Carpten JD, Xu J, Zheng SL, et al.
Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations. Prostate.
2008;
68(12):1257-1262.
Bowden DW, Lehtinen AB, Ziegler JT, Rudock ME, Xu J, Wagenknecht LE, Herrington DM, Rich SS, Freedman BI, Carr JJ, Langefeld CD.
Genetic epidemiology of subclinical cardiovascular disease in the Diabetes Heart Study. Ann Hum Genet.
2008;
72(Pt 5):598-610.
Sun J, Zheng SL, Purcell LD, Gao Z, Hsu F-C, Kim S-T, Liu W, Zhu Y, Dimitrov L, Sun J, Li T, Turner AR, Adams TS, Chang B-L, Xu J, et al.
Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet.
2008;
40(10):1153-1155.
Xu J, Sun J, Li G, Zhu Y, Hsu F-C, Turner AR, Adams TS, Liu W, Chang B, Zheng S, et al.
Association of prostate cancer risk variants with clinicopathologic characteristics of the disease. Clin Cancer Res.
2008;
14(18):5819-5824.
Liu W, Xie CC, Zhu Y, Li T, Sun J, Cheng Y, Turner AR, Sun J, Chang B-L, Zheng SL, Xu J, et al.
Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer. Neoplasia.
2008;
10(8):897-907.
Ohar JA, Holian A, Sadeghnejad A, Hamilton RF, Zheng SL, Xu J, Meyers DA, Bleecker ER.
Polymorphisms in MSR1 gene affect macrophage function [abstract]. Am J Respir Crit Care Med.
2008;
177(Online Abstr Issue):A503.
Liu W, Chang B, Li T, Dimitrov L, Kim S, Kim JW, Turner AR, Meyers DA, Zheng SL, Xu J, et al.
Germline copy number polymorphisms involving larger than 100 kb are uncommon in normal subjects. Prostate.
2007;
67(3):227-233.
Sun J, Liu W, Adams TS, Sun J, Li X, Turner AR, Chang B, Kim JW, Zheng SL, Xu J, et al.
DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies. Prostate.
2007;
67(7):692-700.
Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, Helgason A, Rafnar T, Bergthorsson JT, Agnarsson BA, Xu J, et al.
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet.
2007;
39(5):631-637.
Camp NJ, Cannon-Albright LA, Farnham JM, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Dimitrov L, Xu J, et al.
Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Hum Mol Genet.
2007;
16(11):1271-1278.
Liu W, Chang B-L, Li T, Sun J, Turner AR, Dimitrov L, Zhu Y, Sun J, Kim JW, Zheng SL, Xu J, et al.
Multiple genomic alterations on 21q22 predict various TMPRSS2/ERG fusion transcripts in human prostate cancers. Genes Chromosomes Cancer.
2007;
46(11):972-980.
Liu W, Chang B-L, Cramer S, Koty PP, Li T, Sun J, Turner AR, Von Hap-Herr C, Zheng SL, Xu J, et al.
Deletion of a small consensus region at 6q15, including the MAP3K7 gene, is significantly associated with high-grade prostate cancers. Clin Cancer Res.
2007;
13(17):5028-5033.
Zheng SL, Sun J, Cheng Y, Li G, Hsu F-C, Zhu Y, Chang B-L, Liu W, Kim JW, Turner AR, Xu J, et al.
Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J Natl Cancer Inst.
2007;
99(20):1525-1533.
Duggan D, Zheng SL, Dimitrov L, Cheng Y, Li G, Sun J, Chang B-L, Liu W, Kim JW, Bleecker ER, Meyers DA, Xu J, et al.
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB21P. J Natl Cancer Inst.
2007;
99(24):1836-1844.
Shahedi K, Lindstrom S, Zheng SL, Wiklund F, Adolfsson J, Sun J, Augustsson-Balter K, Chang B-L, Liu W, Xu J, et al.
Genetic variation in the COX-2 gene and the association with prostate cancer risk. Int J Cancer.
2006;
119(3):668-672.
Liu W, Chang B, Sauvageot J, Dimitrov L, Gielzak M, Li T, Yan G, Sun J, Sun J, Adams TS, Turner AR, Kim JW, Meyers DA, Zheng SL, Isaacs WB, Xu J.
Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array. Genes Chromosomes Cancer.
2006;
45(11):1018-1032.
Freedman BI, Hsu FC, Lohman K, Bowden DW, Leonchik L [sic] [Lenchik L], Langefeld CD, Xu J, Register Tc, Rich SS, Wagenknecht LE.
The relationship between calcified atherosclerotic plaque and bone mineral density: the Diabetes Heart Study [abstract]. Atheroscler Suppl.
2006;
7(3):14.
Zheng SL, Liu W, Dimitrov L, Sun J, Sun J, Chang B, Loza M, Turner AR, Bleecker ER, Meyers DA, Xu J, et al.
A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS Study. Prostate.
2006;
66(14):1556-1564.
Lindstrom S, Zheng SL, Wiklund F, Jonsson B-A, Adami H-O, Balter KA, Brookes AJ, Sun J, Chang B-L, Liu W, Li G, Xu J, et al.
Systematic replication study of reported genetic associations in prostate cancer: strong support for genetic variation in the androgen pathway. Prostate.
2006;
66(16):1729-1743.
Hedelin M, Chang ET, Wiklund F, Bellocco R, Klint A, Adolfsson J, Shahedi K, Xu J, Adami H-O, Gronberg H, Balter KA.
Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism. Int J Cancer.
2006;
120(2):398-405.
All Publications
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.